Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib.

Autor: Campregher PV; a Department of Hematology and Clinical Pathology , Research Institute, Hospital Israelita Albert Einstein , São Paulo , Brazil.; b Foundation Medicine , Cambridge , MT.; c Department of Hematology, University of Campinas (Hemocentro - Unicamp) , Campinas , São Paulo , Brazil., Halley NDS; d Department of Pediatric , Hospital Israelita Albert Einstein , São Paulo , Brazil., Vieira GA; a Department of Hematology and Clinical Pathology , Research Institute, Hospital Israelita Albert Einstein , São Paulo , Brazil., Fernandes JF; e Hematology and Bone Marrow Transplantation Program , Hospital Israelita Albert Einstein , São Paulo , Brazil., Velloso EDRP; f Hematology Service , Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo , São Paulo , Brazil.; g Cytogenetics Laboratories , Hospital Israelita Albert Einstein , São Paulo , Brazil., Ali S; b Foundation Medicine , Cambridge , MT., Mughal T; h Tufts University Cancer Center , Boston , MA , USA., Miller V; b Foundation Medicine , Cambridge , MT., Mangueira CLP; a Department of Hematology and Clinical Pathology , Research Institute, Hospital Israelita Albert Einstein , São Paulo , Brazil., Odone V; i Department of Pediatric Oncology , Hospital Israelita Albert Einstein , São Paulo , Brazil., Hamerschlak N; j Department of Hematology , Hospital Israelita Albert Einstein , São Paulo , Brazil.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2017 Dec; Vol. 58 (12), pp. 2969-2972. Date of Electronic Publication: 2017 May 16.